Never Miss a Biotech Catalyst
Track PDUFA dates, Phase 3 results, and FDA decisions for 1,169+ biotech stocks. Get ahead of market-moving events with comprehensive catalyst coverage.
Data updated 7m ago
Upcoming Catalysts
The next big biotech events
BAY3283142 Phase 2 Results Expected
BAYER
FDA PDUFA Date JZP-458 (priority)
Jazz Pharmaceuticals plc
Placebo Phase 2 Results Expected
Alto Neuroscience, Inc.
MVA-HBV Phase 2 Results Expected
Barinthus Biotherapeutics plc.
LY3871801 Phase 2 Results Expected
Eli Lilly and Company
Recent Results
Latest FDA decisions and trial outcomes
FDA PDUFA Date Hetlioz (standard)
Vanda Pharmaceuticals Inc.
FDA PDUFA Date Tirzepatide (standard)
Sanofi
FDA PDUFA Date Sutimlimab (priority)
Sanofi
FDA PDUFA Date leniolisib (priority)
Pharming Group N.V.
FDA PDUFA Date OMIDRIA (standard)
Omeros Corporation
Upcoming Biotech IPOs
Track initial public offerings from biotechnology and pharmaceutical companies
Biotech IPOs
Total Deal Value
Why Track IPOs?
Biotech IPOs offer early access to innovative companies developing breakthrough therapies. Stay informed about new investment opportunities.
Explore IPOsMake Smarter Investment Decisions
Our machine learning models analyze thousands of clinical trials and FDA decisions to predict outcomes and help you understand the biotech landscape.
- Directional prediction (up/down/neutral)
- Confidence score with key factors
- Trained on 880+ catalyst patterns
- Phase-specific success rates
- Therapeutic area benchmarks
- Designation impact analysis
- Phase transition success rates
- Therapeutic area LOA data
- Historical trend analysis
Source: BIO Industry Analysis 2024
Higher rates indicate historically better approval odds
Data-Driven Predictions You Can Trust
1. Data Collection: We collect historical data from ClinicalTrials.gov, FDA decisions, and market data.
2. Feature Engineering: Our models analyze phase, therapeutic area, designations, market cap, and more.
3. Model Training: XGBoost for impact prediction, Random Forest for LOA - calibrated for accurate probabilities.
4. Continuous Learning: Models retrain weekly with new outcomes to improve accuracy.
Predictions are for informational purposes only and NOT financial advice. Past performance does not guarantee future results. Always conduct your own research and consult a financial advisor before making investment decisions.
Everything You Need
Professional biotech intelligence for serious investors
Why CatalystAlert?
Real-time Updates
Data synced daily from ClinicalTrials.gov, SEC filings, and FDA announcements
Official Sources
All data comes directly from government databases and official company filings
Tiered Access
Free tier for browsing, premium tiers unlock ML predictions and alerts
Data Sources
- ClinicalTrials.gov - Clinical trial phases and timelines
- SEC EDGAR - 8-K filings and press releases
- FDA openFDA - Drug approvals and PDUFA dates
Important Disclaimer
CatalystAlert is an informational platform only and does NOT provide financial advice. All predictions and analyses are based on historical data and are not guarantees of future results. Biotech investing carries significant risk including potential total loss of investment. Always consult a qualified financial advisor before making investment decisions. Full Terms
Start Trading Smarter
Join thousands of biotech traders using AI-powered predictions to time their entries. Free tier available, upgrade anytime for ML predictions and alerts.